Bank of Montreal has taken a significant step in its financial strategy by filing a pricing supplement for a new offering of senior medium-term notes. This offering, totaling $978,000, is linked to the performance of stocks from Costco Wholesale Corporation and Dell Technologies Inc.
The notes are designed for investors looking for monthly contingent interest payments and a return of principal, depending on the performance of the linked assets. This move is indicative of the bank's ongoing efforts to diversify its financial products and cater to a wider range of investor needs.
Background
Bank of Montreal, incorporated in Canada, operates under the SIC classification of Commercial Banks, NEC (6029). The bank is publicly traded on the New York Stock Exchange under the ticker symbol BMO. Recent filings include multiple 424B2 forms, with the latest dated October 29, 2026.
What the Filing Says
The filing, identified by accession number 0001214659-26-013417, outlines the specifics of the new notes. The notes are categorized as autocallable barrier notes with memory coupons due on October 31, 2029. They offer a contingent interest rate of 1.3083% per month, translating to approximately 15.70% per annum, contingent on the performance of the reference assets.
Impact
This offering may attract a diverse group of investors interested in structured products that offer potential returns based on stock performance. The notes are particularly aimed at those who are willing to accept the risks associated with the underlying assets, including the possibility of losing principal.
What's Next
The filing does not say what happens next, but the issuance of these notes indicates Bank of Montreal's commitment to expanding its product offerings within the commercial banking sector.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










